One-Time_Notification_Manual / 129

Why This Topic Matters

The article helps users identify which 2005-era drug administration reporting changes were being introduced under Medicare and how CMS framed the transition to the later CPT structure. It is relevant to organizations updating charge capture, claims processing, and coding education for infusion, injection, and chemotherapy administration services.

Article Sections

1. Summary of Changes

   Overview of the notice purpose, publication timing, and the general scope of the coding revisions. Introduces the relationship between Medicare guidance and the evolving CPT framework.

2. General Information

   Background on the policy basis for the revisions and the CMS/AMA process used to develop them. Covers the role of stakeholder groups and the transition from older coding structures to the updated approach.

3. Policy

   General policy discussion of how the new 2005 drug administration coding structure was organized and implemented. Addresses broad categories of services, effective periods, and related reporting concepts.

4. New G-Codes for Hydration Services

   High-level discussion of the hydration service category within the revised drug administration framework. Explains the scope of the section and how hydration services were treated under the new Medicare guidance.

5. New G-Codes for Nonchemotherapy Therapeutic or Diagnostic Injections and IV Infusions (other than Hydration)

   Covers the nonchemotherapy infusion and injection category within the revised coding structure. Includes discussion of related administration types, sequencing concepts, and broader reporting considerations.

6. New G-Codes for Chemotherapy Administration

   Summarizes the chemotherapy administration category and its expanded scope under the 2005 guidance. Discusses the overall structure of related codes and associated reporting topics.

7. Add-On Codes

   Explains the general role of add-on drug administration codes in the revised framework. Describes how these codes fit within broader billing relationships without detailing selection rules.

8. Billing of Code 99211

   Brief billing guidance related to code 99211 in connection with drug administration services. Focuses on the policy context rather than operational specifics.

9. 2005 Drug Administration G Codes

   References the consolidated presentation of the 2005 drug administration code set as provided in the source document. Serves as a locating point for the code listing included in the notice.

10. Partial List of Drug Commonly Considered to be Monoclonal Antibodies and Hormonal Antineoplastics

    Identifies examples of drug classes discussed in the notice’s broader chemotherapy administration context. Provides a general reference to substances mentioned in connection with the guidance.

11. Provider Education

    Describes the availability of CMS provider education materials related to the instruction. Focuses on dissemination and contractor communication expectations.

12. Business Requirements

    Administrative and implementation-oriented requirements for contractors. Includes general operational notes and references to supporting material.

13. Supporting Information and Possible Design Considerations

    Supplemental implementation information and design-related notes for contractors. Organizes dependency, interface, testing, and related administrative considerations.

14. Schedule, Contacts, and Funding

    Implementation dates, contact points, and funding notes associated with the notice. Provides administrative reference information for rollout and support.